G P Clagett, E W Salzman. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Administration, OralAnticoagulants/adverse effectsAspirin/pharmacologyBlood Platelets/drug effectsBurns/complicationsDextrans/adverse effectsDextrans/therapeutic useDipyridamole/pharmacologyFemaleHemorrhage/chemically inducedHeparin/administration & dosageHeparin/therapeutic useHumansHydroxychloroquine/pharmacologyOrthopedicsPostoperative Complications/prevention & controlPregnancyPregnancy Complications, Cardiovascular/prevention & controlPulmonary Embolism/etiologyThromboembolism/drug therapyThromboembolism/etiologyThromboembolism/prevention & controlUrologic Diseases/surgeryVeins
Substances： See more » AnticoagulantsDextransHydroxychloroquineDipyridamoleHeparinAspirin
Year: 1975 PMID： 1093235 DOI： 10.1016/s0033-0620(75)80011-9
Source DB: PubMed Journal: Prog Cardiovasc Dis ISSN： 0033-0620 Impact factor: 8.194